Tag: technology company

Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations

FREMONT, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that it is continuing to expand its product offering in Europe to meet the needs of customers with initial shipments of IQ8P™ Microinverters, with peak output AC power of 480 W, in Italy and Switzerland to support newer, high-powered solar modules.

New York, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that it has joined the Canadian Nuclear Association (CNA), the leading Canadian nuclear industry advocacy group since 1960.

Irvine, CA, July 24, 2025 (GLOBE NEWSWIRE) -- Linkhome Holdings Inc. (“Linkhome” or the “Company”) (Nasdaq: LHAI), a leading AI-powered real estate platform leveraging artificial intelligence and fintech to make homeownership simpler, faster, and more accessible for all Americans, today announced the pricing of its upsized initial public offering (the “Offering”). The Offering consists of 1,500,000 shares of common stock priced at a public offering price of $4 per share, for total gross proceeds of $6,000,000, before deducting underwriting discounts and offering expenses. The shares of common stock have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on Jul 24, 2025, under the ticker symbol “LHAI.”

DUBLIN, Ohio, July 23, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced that it has repaid in full the outstanding balance on its secured promissory note with Streeterville Capital, LLC (“Streeterville”).

MALVERN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 45^th Annual Growth Conference.

New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurate HiFi sequencing

Milestone demonstrates NANO Nuclear’s ability to bring advanced nuclear technology from initial design to construction and demonstration